欢迎来到天天文库
浏览记录
ID:56068961
大小:345.59 KB
页数:4页
时间:2020-06-20
《参芪地黄汤加减治疗2型糖尿病合并膜性肾病30例临床观察.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、1332阿北中医2014年9月第36卷第9期HebeiJTCM,September2014,Vol36⋯No.9.毫:蠹嚣薯:要-瓤:::至薹誊-。一=:薯萼彗×誊。.杀蠹:参芪地黄汤加减治疗2型糖尿病合并膜性肾病3O例临床观察※孔令新王艳云田朝阳李莉(北京市房山区中医医院肾病科,北京102400)【摘要】目的观察参芪地黄汤加减治疗2型糖尿病合并膜性肾病临床疗效。方法将60例2型糖尿病合并膜性肾病患者随机分为2组。对照组3O例予西医常规治疗,治疗组30例在对照组治疗基础上加用参芪地黄汤加减治疗。
2、2组均3个月为1个疗程,1个疗程后统计疗效,并观察2组治疗前后中医证候积分、24h尿蛋白定量(24Upro)、血清白蛋白(Alb)、血清肌酐(Cr)、糖化血红蛋白(HbAlc)及总胆固醇(Tc)。结果2组中医、西医总有效率比较差异均有统计学意义(P<0.05),治疗组疗效优于对照组。2组治疗后中医证候积分、24Upro均降低(P<0.05),且治疗组降低优于对照组(P<0.05);2组治疗后Alh均升高(P<0.05),且治疗组升高优于对照组(P<0.05)。2组治疗后Cr、HbAlc及TC与本
3、组治疗前及组间比较差异无统计学意义(P>0.05)。结论参芪地黄汤加减治疗2型糖尿病合并膜性肾病疗效确切。【关键词】糖尿病;并发症;肾小球肾炎,膜性;中药疗法【中图分类号】R280.5;~.115.31;RID2.310.531【文献标识码】A【文章编号】11312—2619(2014)09—1332—04InvestigationofSbenqiDihuangdecoctiononthetreatmentoftype2diabeteswithmembranousnephropathyKONGL
4、ingxin,WANGYanyun,TIANZhaoyang,eta1.DivisionofNephrosis,FangshanDistrictHospitalofTraditionalChineseMedicineinBeng,Beng102400【Abstract】ObjectiveToinvestigatetheclinicaleffectofShenqiDihuangdecoctionO1"1thetreatmentoftype2diabeteswithmembranousnephrop
5、athy.Methods60casesoftype2diabeteswithmembranousnephropathywererandomlydividedintotwogroups.Patientsincontrolgroup(n=30)weretreatedbywesternconventionaltreatment.Patientsintreatmentgroup(n=30)weretreatedbyShenqiDihuangdecoctionOilthebasisofcontrolgro
6、uptreat—ment.nlecoursewasthreemonthsintwogroups.Thetherapeuticeffectwasevaluatedafteracourse.TCMscore.24Upro,Alb,Cr,HbAlcandTCinserumwereobservedbeforeandaftertreatmentintwogroups.ResultsTherewassignificantdiferencebetweenwesternmedicineandtraditiona
7、lChinesemedicineonthetotalefectiverateintwogroups(P<0.05).Thetherapeuticefectintreatmentgroupwassuperiortothatincontrolgroup.TCMscoreand24Uproaftertreatmentweredecreasedintwogroups(P<0.05).Thedecreaseintreatmentgroupwassuperiortothatincontrolgroup(P<
8、0.05).Albaftertreatmentwereincreasedintwogroups(P<0.05).rheincreaseintreatmentgroupwassuperiortothatincontrolgroup(P<0.05).TherewasnosignificantdifferencebetweenbeforeandaftertreatmentonCr,HbAlcandAlbintwogroups(P>0.05).ConclusionShenqiDihuangdecocti
此文档下载收益归作者所有